Related Experiment Video
Updated: Jun 9, 2025

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
Published on: July 28, 2023
Genistein inhibited endocytosis and fibrogenesis in keloid via CTGF signaling pathways
Chun-Te Lu1,2, Jiunn-Liang Ko3,4, Chu-Chyn Ou5,6
1Division of Plastic and Reconstructive Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, 407, Taiwan.
Background:
This study aimed to evaluate soy isoflavones' effect and potential use-specifically genistein-in treating human keloid fibroblast cells (KFs) and in a keloid tissue culture model.
Methods:
To investigate the effects of genistein on keloid, a wound-healing assay was performed to detect cell migration. Flow cytometry was used to measure apoptosis. Western blotting and immunofluorescence staining were performed to detect the expression of target proteins. KF tissues were isolated, cultured, and divided into the control, silenced connective tissue growth factor (CTGF) proteins, and shNC (negative control) groups.
Results:
Genistein suppressed cell proliferation and migration, triggering the cell cycle at the G2/M phase and increasing the expression of p53 dose-dependent in keloids. Genistein inhibited the expression of COL1A1, FN, and CTGF mRNA and protein. Knockdown CTGF reduced the migrated ability in KFs. Genistein also abated TGF-β1-induced keloid fibrosis through the endocytosis model. Separated and cultured the keloid patient's tissues decreased the cell migration ability by genistein treatment and was time-dose dependent.
Conclusions:
This study indicated that genistein-induced p53 undergoes cell cycle arrest via the CTGF pathway-inhibited keloid cultured cells, and genistein suppressed the primary keloid cell migration, suggesting that our research provides a new strategy for developing drugs for treating keloids.
Insights
Genistein, a soy isoflavone, effectively inhibits keloid fibroblast cell migration and proliferation by inducing cell cycle arrest via the CTGF pathway. This research offers a novel therapeutic strategy for keloid treatment.
Area of Science:
- Biochemistry
- Dermatology
- Cell Biology
Background:
- Keloids are abnormal scars resulting from excessive fibroblast activity.
- Soy isoflavones, particularly genistein, are investigated for their therapeutic potential.
- Human keloid fibroblast cells (KFs) and tissue models are used to study keloid pathogenesis.
Purpose of the Study:
- To evaluate the effects of genistein on keloid fibroblast cells and tissue.
- To investigate genistein's mechanism of action in keloid treatment.
- To explore genistein as a potential therapeutic agent for keloids.
Main Methods:
- Cell migration assays (wound-healing) were performed.
- Apoptosis was measured using flow cytometry.
- Protein and mRNA expression (COL1A1, FN, CTGF, p53) were analyzed via Western blotting and immunofluorescence.
- Connective tissue growth factor (CTGF) knockdown was utilized.
Main Results:
- Genistein suppressed KF proliferation and migration, inducing G2/M cell cycle arrest and upregulating p53.
- Genistein inhibited COL1A1, FN, and CTGF expression.
- CTGF knockdown reduced KF migration.
- Genistein mitigated TGF-β1-induced fibrosis and reduced cell migration in a time- and dose-dependent manner.
Conclusions:
- Genistein-induced p53 triggers cell cycle arrest through the CTGF pathway, inhibiting keloid cell proliferation.
- Genistein effectively suppresses keloid cell migration.
- This study presents genistein as a promising therapeutic strategy for keloid treatment.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

